Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Compr…
Medical - Diagnostics & Research
US, Temple City [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Fulgent Genetics, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2016 | - | 0.327 | - | 18 | - | 9 | - | 5 | - | 4 | - | 4 |
| 2017 | -0.3000 | 0.003 | 18 | 19 | -5 | -8 | 2 | -7 | 0.92 | -11 | 7 | 4 |
| 2018 | -0.1500 | -0.095 | 18 | 21 | -2 | -5 | -1 | -2 | -3 | -4 | 9 | 9 |
| 2019 | -0.2500 | 0.114 | 21 | 32 | -4 | 3 | -2 | 9 | -5 | 8 | 10 | 7 |
| 2020 | 0.0196 | 6.258 | 32 | 326 | 0.37 | 186 | 1 | 98 | 0.43 | 81 | 12 | 79 |
| 2021 | 9.6400 | 15.683 | 421 | 933 | 214 | 460 | 290 | 627 | 290 | 610 | 30 | 66 |
| 2022 | 17.1300 | 5.612 | 992 | 610 | 507 | 336 | 675 | 472 | 675 | 448 | 75 | 105 |
| 2023 | 4.7600 | -0.976 | 618 | 278 | 143 | -167 | 221 | 90 | 181 | 76 | 149 | 122 |
| 2024 | -5.6300 | 0.325 | 289 | 281 | -167 | 9 | -46 | 91 | -67 | 77 | 130 | 68 |
| 2025 | - | -0.154 | - | 324 | - | -4 | - | 105 | - | 88 | - | 79 |
| 2026 | - | 0.F10X/td> | - | 0.F10X/td> | - | 0.F10X/td> | - | 0.F101/td> | - | 0.F101 | - | 0.F101 |